ELSs with a network of CXCL13+ cells, have been detected in the meninges of approximately 40% of secondary progressive MS (SPMS) patients, and are associated with more severe disease course and cortical lesions (69, 136–138). This evidence concerns the gene CXCL13 and secondary progressive multiple sclerosis.